Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Mesothelioma: HELP
Michele Maio
Based on 11 articles published since 2008
||||
Expertise Level
The expertise of Michele Maio ranks in the
  • Top 0.35%
  • ... of 16,700 published authors worldwide on Mesothelioma
  • ... from 2008 through 2019
  • ... based on contributions to 11 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Work Locations
Details
Most likely:    Azienda Ospedaliera Universitaria Senese      
2018
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Pubmed 29943157
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Euganea Medica Radiology Center, Padua, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Translational Sciences, Pathology, MedImmune, Granta Park, Cambridge, UK. · MedImmune, Gaithersburg, MD, USA. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 29773326
2017
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Thoracic & GU Oncology Unit Department of Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pulmonary and Thoracic Oncology, CHU de Lille, Univ Lille, Mesoclin Network, F59000 Lille, France. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28736182
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pulmonary and Thoracic Oncology, University of Lille, CHU de Lille, Lille, France. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Erasmus Medical Center, Rotterdam, Netherlands. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Centro di Riferimento Oncologico di Aviano, Pordenone, Italy. · KU Leuven-University of Leuven, University Hospitals, Leuven, Belgium. · University Hospitals of Leicester, Leicester, UK. · Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University Hospital of South Manchester, Manchester, UK. · Mesothelioma Unit-Medical Oncology Department, SS Antonio e Biagio General Hospital, Alessandria, Italy. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia. · AstraZeneca, Alderley Park, Macclesfield, UK. · AstraZeneca, Cambridge, UK. · Department of Medicine, University of Chicago, Chicago, IL, USA. · Pubmed 28729154
2015
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 25965359
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 25819643
2014
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. Electronic address: · Pubmed 24384489
2013
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Department of Medicine, Laboratory of Clinical Oncology, Hospital of Vercelli, Vercelli, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 24035405
2015
  • Immunoterapia Oncologica, Dipartimento di Oncologia Medica, Istituto Toscano Tumori, Azienda Ospedaliera Universitaria Senese, Viale Mario Bracci n. 16, 53100, Siena, Italy, · Pubmed 25233793
2011
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21792917
2010
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21074061
Probable:    Istituto Toscano Tumori      
2018
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Pubmed 29943157
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Euganea Medica Radiology Center, Padua, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Translational Sciences, Pathology, MedImmune, Granta Park, Cambridge, UK. · MedImmune, Gaithersburg, MD, USA. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 29773326
2017
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Thoracic & GU Oncology Unit Department of Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pulmonary and Thoracic Oncology, CHU de Lille, Univ Lille, Mesoclin Network, F59000 Lille, France. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28736182
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pulmonary and Thoracic Oncology, University of Lille, CHU de Lille, Lille, France. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Erasmus Medical Center, Rotterdam, Netherlands. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Centro di Riferimento Oncologico di Aviano, Pordenone, Italy. · KU Leuven-University of Leuven, University Hospitals, Leuven, Belgium. · University Hospitals of Leicester, Leicester, UK. · Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University Hospital of South Manchester, Manchester, UK. · Mesothelioma Unit-Medical Oncology Department, SS Antonio e Biagio General Hospital, Alessandria, Italy. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia. · AstraZeneca, Alderley Park, Macclesfield, UK. · AstraZeneca, Cambridge, UK. · Department of Medicine, University of Chicago, Chicago, IL, USA. · Pubmed 28729154
2015
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 25965359
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 25819643
2014
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. Electronic address: · Pubmed 24384489
2013
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Department of Medicine, Laboratory of Clinical Oncology, Hospital of Vercelli, Vercelli, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 24035405
2015
  • Immunoterapia Oncologica, Dipartimento di Oncologia Medica, Istituto Toscano Tumori, Azienda Ospedaliera Universitaria Senese, Viale Mario Bracci n. 16, 53100, Siena, Italy, · Pubmed 25233793
2011
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21792917
2010
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21074061
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 11 total) written by Michele Maio about Mesothelioma:

  • Immune checkpoint blockade therapy of mesothelioma: a clinical and radiological challenge. 2018
  • Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study. 2018
  • Immune checkpoint therapy of mesothelioma: Pre-clinical bases and clinical evidences. 2017
  • Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial. 2017
  • Immune checkpoint blockade in malignant mesothelioma. 2015
  • CTLA4 blockade in mesothelioma: finally a competing strategy over cytotoxic/target therapy? 2015
  • Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study. 2015
  • Biomarkers for immune checkpoint inhibitors--authors' reply. 2014
  • Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial. 2013
  • Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: immunotherapeutic implications. 2011
Show List of Full Article Records
Google Searches

Learn more about Michele Maio using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Azienda Ospedaliera Universitaria Senese
Istituto Toscano Tumori
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Azienda Ospedaliera Universitaria Senese
2018
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Pubmed 29943157
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Euganea Medica Radiology Center, Padua, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Translational Sciences, Pathology, MedImmune, Granta Park, Cambridge, UK. · MedImmune, Gaithersburg, MD, USA. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 29773326
2017
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Thoracic & GU Oncology Unit Department of Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pulmonary and Thoracic Oncology, CHU de Lille, Univ Lille, Mesoclin Network, F59000 Lille, France. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28736182
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pulmonary and Thoracic Oncology, University of Lille, CHU de Lille, Lille, France. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Erasmus Medical Center, Rotterdam, Netherlands. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Centro di Riferimento Oncologico di Aviano, Pordenone, Italy. · KU Leuven-University of Leuven, University Hospitals, Leuven, Belgium. · University Hospitals of Leicester, Leicester, UK. · Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University Hospital of South Manchester, Manchester, UK. · Mesothelioma Unit-Medical Oncology Department, SS Antonio e Biagio General Hospital, Alessandria, Italy. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia. · AstraZeneca, Alderley Park, Macclesfield, UK. · AstraZeneca, Cambridge, UK. · Department of Medicine, University of Chicago, Chicago, IL, USA. · Pubmed 28729154
2015
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 25965359
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 25819643
2014
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. Electronic address: · Pubmed 24384489
2013
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Department of Medicine, Laboratory of Clinical Oncology, Hospital of Vercelli, Vercelli, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 24035405
2015
  • Immunoterapia Oncologica, Dipartimento di Oncologia Medica, Istituto Toscano Tumori, Azienda Ospedaliera Universitaria Senese, Viale Mario Bracci n. 16, 53100, Siena, Italy, · Pubmed 25233793
2011
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21792917
2010
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21074061
Istituto Toscano Tumori
2018
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Viale Mario Bracci n. 16, 53100, Siena, Italy. · Pubmed 29943157
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Euganea Medica Radiology Center, Padua, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Translational Sciences, Pathology, MedImmune, Granta Park, Cambridge, UK. · MedImmune, Gaithersburg, MD, USA. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 29773326
2017
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Thoracic & GU Oncology Unit Department of Oncology, Cliniche Humanitas Gavazzeni, Bergamo, Italy. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pulmonary and Thoracic Oncology, CHU de Lille, Univ Lille, Mesoclin Network, F59000 Lille, France. · Erasmus MC Cancer Institute, Rotterdam, The Netherlands. · Pubmed 28736182
  • Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pulmonary and Thoracic Oncology, University of Lille, CHU de Lille, Lille, France. · Medical Oncology and Immunotherapy, Center for Immuno-Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Erasmus Medical Center, Rotterdam, Netherlands. · Vall d'Hebron Institute of Oncology, Barcelona, Spain. · Centro di Riferimento Oncologico di Aviano, Pordenone, Italy. · KU Leuven-University of Leuven, University Hospitals, Leuven, Belgium. · University Hospitals of Leicester, Leicester, UK. · Maria Sklodowska-Curie Institute of Oncology, Warsaw, Poland. · The University of Texas MD Anderson Cancer Center, Houston, TX, USA. · University Hospital of South Manchester, Manchester, UK. · Mesothelioma Unit-Medical Oncology Department, SS Antonio e Biagio General Hospital, Alessandria, Italy. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · School of Medicine and Pharmacology, University of Western Australia, Perth, WA, Australia; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia. · AstraZeneca, Alderley Park, Macclesfield, UK. · AstraZeneca, Cambridge, UK. · Department of Medicine, University of Chicago, Chicago, IL, USA. · Pubmed 28729154
2015
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 25965359
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 25819643
2014
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, 53100 Siena, Italy. Electronic address: · Pubmed 24384489
2013
  • Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Department of Radiology, Euganea Medica Diagnostic Center, Padua, Italy. · Statistics, Regina Elena National Cancer Institute, Rome, Italy. · Department of Medicine, Laboratory of Clinical Oncology, Hospital of Vercelli, Vercelli, Italy. · Medical Oncology and Immunotherapy, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. Electronic address: · Pubmed 24035405
2015
  • Immunoterapia Oncologica, Dipartimento di Oncologia Medica, Istituto Toscano Tumori, Azienda Ospedaliera Universitaria Senese, Viale Mario Bracci n. 16, 53100, Siena, Italy, · Pubmed 25233793
2011
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21792917
2010
  • Division of Medical Oncology and Immunotherapy, Department of Oncology, University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy. · Pubmed 21074061
Yearly article counts 022031101100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.